Search

Search bills, members, committees and pages...

Sign In

CHRISTOPHER PORTER

PreviousNext

14 federal lobbying filings, 2023 to 2026.

CHRISTOPHER PORTER is a registered lobbyist named on 14 federal lobbying filings, 2023 to 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

1 they have filed under, by filings.

RegistrantFilingsReported
TRAVERE THERAPEUTICS14—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262—$340K
20254—$730K
20244—$530K
20234—$620K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
CPTCopyright/Patent/Trademark14
HCRHealth Issues14
MEDMedical/Disease Research/Clinical Labs14
MMMMedicare/Medicaid14
PHAPharmacy14
TAXTaxation/Internal Revenue Code14

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1262Mikaela Naylon Give Kids a Chance Act6
H.R. 1414Cameron’s Law6
H.R. 1518New Era of Preventing End-Stage Kidney Disease Act6
H.R. 946ORPHAN Cures Act6
S. 1040Drug Competition Enhancement Act6
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.5
S. 1862ORPHAN Cures Act5
H.R. 4709Newborn Screening Saves Lives Reauthorization Act of 20254
H.R. 9102BINSA Act1
S. 2658Medication Affordability and Patent Integrity Act1

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2026 second_quarter$140KJul 20, 2026
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2026 first_quarter$200KApr 20, 2026
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2025 fourth_quarter$260KJan 20, 2026
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2025 third_quarter$110KOct 16, 2025
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2025 second_quarter$200KJul 17, 2025
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2025 first_quarter$160KApr 16, 2025
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2024 fourth_quarter$100KFeb 4, 2025
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2024 third_quarter$120KOct 18, 2024
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2024 second_quarter$140KJul 19, 2024
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2024 first_quarter$170KApr 22, 2024
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2023 fourth_quarter$105KJan 22, 2024
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2023 third_quarter$175KOct 17, 2023
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2023 second_quarter$160KJul 19, 2023
TRAVERE THERAPEUTICSTRAVERE THERAPEUTICS2023 first_quarter$180KApr 24, 2023